SCMP Business18/11 14:00 (HKT)
Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital

Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior executive at a local biotech start-up. Yicura BioMed, based in the Hong Kong Science Park, is heading towards an initial pub